Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02750371 : Effect of Irradiation of the Cavernous Sinus and the Sellar Region on Autobiographical Memory
PhaseN/A
AgesMin: 35 Years Max: 65 Years
Eligibility
Inclusion Criteria:

- Age between 35 and 65.

- Patient with:

- meningioma of the cavernous sinus for which radiotherapy is planned

- or a pituitary adenoma for which radiotherapy is planned

- French Mother tongue

- Person affiliated to national insurance

- Person who give its verbal agreement to participate

Exclusion Criteria:

- Presence of a serious psychiatric disorder (major depression, psychotic disorders,
etc.) and central nervous system disease (epilepsy, multiple sclerosis, etc.).

- Treatment with chemotherapy

- General intellectual abilities deficient (IQ <80)

- Extension front of their meningioma

- Deficient Language Skills.
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02750371      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740